Together with the SAB and staff Dr. M. has undertaken a strategic trial path that is based on Precision Medicine.
True but I did not know you meant that with new/old school. What I meant is that there has been some thought about A273 getting (provisional) approval based on signs of patients, care givers and the health care system... is what I do not believe. I thought you meant that too.
The only way anavex will get approval is by delivering statistical evidence it works.